Phibro Animal Health Corporation (PAHC) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of Phibro Animal Health Corporation and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PAHC vs RAPP

growth of $100 · dividends reinvested · last 2y
PAHC +124.7% (+49.9%/yr)RAPP +54.8% (+24.4%/yr)PAHC compounded faster over this window
100200300Start $10020252026$225$155
PAHC RAPP

PAHC vs RAPP: by the numbers

  • •PAHC is the larger company ($1.50B vs $1.49B market cap).
  • •PAHC is profitable (6.57% net margin) while RAPP runs a net loss (-685.80%).
  • •PAHC pays a dividend (1.29% yield), while RAPP has no payments in the available dividend history.

Metrics side by side

Valuation

MetricPAHCRAPP
P/E ratio15.17N/A
Forward P/E10.57N/A
PEG ratio1.19N/A
P/S ratio0.9974.29
P/B ratio3.893.51
EV / EBITDA8.91N/A
FCF yield0.66%N/A

Profitability

MetricPAHCRAPP
Gross margin33.71%0.00%
Operating margin13.07%0.00%
Net margin6.57%-685.80%
ROE25.87%-32.43%
ROIC11.91%-35.66%

Dividends

MetricPAHCRAPP
Dividend yield1.29%N/A
Payout ratio19.67%N/A

Growth (annualized)

MetricPAHCRAPP
Revenue CAGR (5Y)12.75%N/A
EPS CAGR (5Y)12.92%N/A
FCF CAGR (5Y)-12.27%N/A
Total return CAGR (5Y)14.40%N/A

Frequently asked

Does PAHC or RAPP pay a bigger dividend?
PAHC pays a dividend (1.29% yield), while RAPP has no payments in the available dividend history.
Is PAHC or RAPP more profitable?
PAHC runs the higher net margin — PAHC at 6.57% versus RAPP at -685.80%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.